1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          Humans with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), a T cell–driven autoimmune disease caused by impaired central tolerance, are susceptible to developing chronic fungal infection and esophageal squamous cell carcinoma (ESCC). However, the relationship between autoreactive T cells and chronic fungal infection in ESCC development remains unclear. We find that kinase-dead Ikkα knockin mice develop phenotypes reminiscent of APECED, including impaired central tolerance, autoreactive T cells, chronic fungal infection, and ESCCs expressing specific human ESCC markers. Using this model, we investigated the potential link between ESCC and fungal infection. Autoreactive CD4 T cells permit fungal infection and incite tissue injury and inflammation. Antifungal treatment or depletion of autoreactive CD4 T cells rescues, whereas oral fungal administration promotes, ESCC development. Inhibition of inflammation or EGFR activity decreases fungal burden. Importantly, fungal infection is highly associated with ESCCs in non-autoimmune human patients. Therefore, autoreactive T cells and chronic fungal infection, fostered by inflammation and epithelial injury, promote ESCC development.

          Related collections

          Author and article information

          Journal
          101302316
          33345
          Cell Host Microbe
          Cell Host Microbe
          Cell host & microbe
          1931-3128
          1934-6069
          12 March 2018
          12 April 2017
          26 March 2018
          : 21
          : 4
          : 478-493.e7
          Affiliations
          [1 ]Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA
          [2 ]Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX 78957, USA
          [3 ]State Key Laboratory of Molecular Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China
          [4 ]Department of Pathology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China
          [5 ]Molecular Genetics Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
          [6 ]Laboratory of Molecular Technology, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA
          [7 ]PZM Diagnostics, LLC, Charleston, WV 25314, USA
          Author notes
          [* ]Correspondence: huy2@ 123456mail.nih.gov , Phone: 301-846-1478, Fax: 301-846-7034
          [8]

          Present address: Department of Genetics and Genomics, Yogi Vemana University, Kadapa, AP 516003, India.

          [9]

          Lead Contact

          Article
          PMC5868740 PMC5868740 5868740 nihpa950043
          10.1016/j.chom.2017.03.006
          5868740
          28407484
          b736a0ac-f7b0-464e-b03d-a26e24522b01
          History
          Categories
          Article

          autoimmune disease,IKKalpha in immunity and carcinogenesis,fungal infection,central tolerance,autoreactive T cells,squamous cell carcinoma

          Comments

          Comment on this article